TrialJournal of the European Academy of Dermatology and Venereology : JEADV2014

Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH.

Y Poulin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.